Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 5, 2025
Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final analysis of the DAYBREAK open-label extension trialKrzysztof W Selmaj, Lawrence Steinman, Giancarlo Comi, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|July 9, 2021
Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension studyHans-Peter Hartung, Tobias Derfuss, Bruce Ac Cree, et al.JCI Insight|December 5, 2017
Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patientsErica L Eggers, Brady A Michel, Hao Wu, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 7, 2023
Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentumBrian G Weinshenker, Dean M Wingerchuk, Ari J Green, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 27, 2022
Association of daily physical activity with brain volumes and cervical spinal cord areas in multiple sclerosisValerie J Block, Shuiting Cheng, Jeremy Juwono, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 4, 2021
Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSDBruce Ac Cree, Jeffrey L Bennett, Ho Jin Kim, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2018
Harnessing electronic medical records to advance research on multiple sclerosisVincent Damotte, Antoine Lizée, Matthew Tremblay, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 5, 2024
Diagnostic performance of central vein sign versus oligoclonal bands for multiple sclerosisKarlo Toljan, Lynn Daboul, Praneeta Raza, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 13, 2023
A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosisLynn Daboul, Carly M O'Donnell, Moein Amin, et al.Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
A Predictive Autoantibody Signature in Multiple SclerosisColin R Zamecnik, Gavin M Sowa, Ahmed Abdelhak, et al.Pageof 4